414 related articles for article (PubMed ID: 30715618)
21. Targeting Wnts at the source--new mechanisms, new biomarkers, new drugs.
Madan B; Virshup DM
Mol Cancer Ther; 2015 May; 14(5):1087-94. PubMed ID: 25901018
[TBL] [Abstract][Full Text] [Related]
22. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.
Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P
Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558
[TBL] [Abstract][Full Text] [Related]
23. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
[TBL] [Abstract][Full Text] [Related]
24. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
25. Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth.
Wang J; Mook RA; Ren XR; Zhang Q; Jing G; Lu M; Spasojevic I; Lyerly HK; Hsu D; Chen W
Bioorg Med Chem; 2018 Nov; 26(20):5435-5442. PubMed ID: 30274939
[TBL] [Abstract][Full Text] [Related]
26. Wnt signaling in cancer.
Zhan T; Rindtorff N; Boutros M
Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
[TBL] [Abstract][Full Text] [Related]
27. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
[TBL] [Abstract][Full Text] [Related]
28. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents.
Teiten MH; Gaascht F; Dicato M; Diederich M
Curr Pharm Biotechnol; 2012 Jan; 13(1):245-54. PubMed ID: 21466435
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
30. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
31. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
32. Is β-Catenin a Druggable Target for Cancer Therapy?
Cui C; Zhou X; Zhang W; Qu Y; Ke X
Trends Biochem Sci; 2018 Aug; 43(8):623-634. PubMed ID: 30056837
[TBL] [Abstract][Full Text] [Related]
33. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
[TBL] [Abstract][Full Text] [Related]
34. Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review).
Xiao YF; Yong X; Tang B; Qin Y; Zhang JW; Zhang D; Xie R; Yang SM
Int J Oncol; 2016 Feb; 48(2):437-49. PubMed ID: 26648421
[TBL] [Abstract][Full Text] [Related]
35. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
36. Targeting Tankyrase to Fight WNT-dependent Tumours.
Thorvaldsen TE
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):81-88. PubMed ID: 28371398
[TBL] [Abstract][Full Text] [Related]
37. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
38. The Wnt signaling pathway in cancer.
Duchartre Y; Kim YM; Kahn M
Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
[TBL] [Abstract][Full Text] [Related]
39. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
40. Mining the Wnt pathway for cancer therapeutics.
Barker N; Clevers H
Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
